scholarly journals TBX2 expression is regulated by PAX3 in the melanocyte lineage

2012 ◽  
Vol 26 (1) ◽  
pp. 67-77 ◽  
Author(s):  
Fang Liu ◽  
Juxiang Cao ◽  
Jinghu Lv ◽  
Liang Dong ◽  
Eric Pier ◽  
...  
Keyword(s):  
Development ◽  
1998 ◽  
Vol 125 (13) ◽  
pp. 2499-2509 ◽  
Author(s):  
J.J. Gibson-Brown ◽  
S.I. Agulnik ◽  
L.M. Silver ◽  
L. Niswander ◽  
V.E. Papaioannou

We have recently shown in mice that four members of the T-box family of transcription factors (Tbx2-Tbx5) are expressed in developing limb buds, and that expression of two of these genes, Tbx4 and Tbx5, is primarily restricted to the developing hindlimbs and forelimbs, respectively. In this report, we investigate the role of these genes in limb specification and development, using the chick as a model system. We induced the formation of ectopic limbs in the flank of chick embryos to examine the relationship between the identity of the limb-specific T-box genes being expressed and the identity of limb structures that subsequently develop. We found that, whereas bud regions expressing Tbx4 developed characteristic leg structures, regions expressing Tbx5 developed characteristic wing features. In addition, heterotopic grafts of limb mesenchyme (wing bud into leg bud, and vice versa), which are known to retain the identity of the donor tissue after transplantation, retained autonomous expression of the appropriate, limb-specific T-box gene, with no evidence of regulation by the host bud. Thus there is a direct relationship between the identity of the structures that develop in normal, ectopic and recombinant limbs, and the identity of the T-box gene(s) being expressed. To investigate the regulation of T-box gene expression during limb development, we employed several other embryological manipulations. By surgically removing the apical ectodermal ridge (AER) from either wing or leg buds, we found that, in contrast to all other genes implicated in the patterning of developing appendages, maintenance of T-box gene expression is not dependent on the continued provision of signals from the AER or the zone of polarizing activity (ZPA). By generating an ectopic ZPA, by grafting a sonic hedgehog (SHH)-expressing cell pellet under the anterior AER, we found that Tbx2 expression can lie downstream of SHH. Finally, by grafting a SHH-expressing cell pellet to the anterior margin of a bud from which the AER had been removed, we found that Tbx2 may be a direct, short-range target of SHH. Our findings suggest that these genes are intimately involved in limb development and the specification of limb identity, and a new model for the evolution of vertebrate appendages is proposed.


2014 ◽  
Vol 45 (4) ◽  
pp. 421-426 ◽  
Author(s):  
Bo Hu ◽  
Hai-Ping Mu ◽  
Yu-Qing Zhang ◽  
Chong-Yi Su ◽  
Jian-Tao Song ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (19) ◽  
pp. 5020
Author(s):  
Girijesh Kumar Patel ◽  
Sayanika Dutta ◽  
Mosharaf Mahmud Syed ◽  
Sabarish Ramachandran ◽  
Monica Sharma ◽  
...  

Deciphering the mechanisms that drive transdifferentiation to neuroendocrine prostate cancer (NEPC) is crucial to identifying novel therapeutic strategies against this lethal and aggressive subtype of advanced prostate cancer (PCa). Further, the role played by exosomal microRNAs (miRs) in mediating signaling mechanisms that propagate the NEPC phenotype remains largely elusive. The unbiased differential miR expression profiling of human PCa cells genetically modulated for TBX2 expression led to the identification of miR-200c-3p. Our findings have unraveled the TBX2/miR-200c-3p/SOX2/N-MYC signaling axis in NEPC transdifferentiation. Mechanistically, we found that: (1) TBX2 binds to the promoter and represses the expression of miR-200c-3p, a miR reported to be lost in castrate resistant prostate cancer (CRPC), and (2) the repression of miR-200c-3p results in the increased expression of its targets SOX2 and N-MYC. In addition, the rescue of mir-200c-3p in the context of TBX2 blockade revealed that miR-200c-3p is the critical intermediary effector in TBX2 regulation of SOX2 and N-MYC. Further, our studies show that in addition to the intracellular mode, TBX2/miR-200c-3p/SOX2/N-MYC signaling can promote NEPC transdifferentiation via exosome-mediated intercellular mechanism, an increasingly recognized and key mode of propagation of the NEPC phenotype.


Oncogene ◽  
2007 ◽  
Vol 27 (7) ◽  
pp. 976-984 ◽  
Author(s):  
E Davis ◽  
H Teng ◽  
B Bilican ◽  
M I Parker ◽  
B Liu ◽  
...  

2009 ◽  
Vol 105 (5) ◽  
pp. 442-452 ◽  
Author(s):  
Reena Singh ◽  
Thomas Horsthuis ◽  
Henner F. Farin ◽  
Thomas Grieskamp ◽  
Julia Norden ◽  
...  

2013 ◽  
Author(s):  
Srinivas Nandana ◽  
Manisha Tripathi ◽  
Murali Gururajan ◽  
Gina Chu ◽  
Robert J. Matusik ◽  
...  

2014 ◽  
Vol 115 (suppl_1) ◽  
Author(s):  
Kyung-Duk Min ◽  
Masanori Asakura ◽  
Shin Ito ◽  
Miki Imazu ◽  
Kazuhiro Shindo ◽  
...  

Background: The bone morphogenetic protein (BMP) pathway plays crucial roles in cardiac development. Recent studies have reported that mutations in Smad9, one of the regulatory Smad specific for the BMP pathway, might result in cardiovascular diseases. However, both regulation and function of Smad9 in the cardiovascular system have not been elucidated. Methods and Results: We conducted DNA microarray using P19CL6 cells with forced expression of Smad9. Microarray analysis using Ingenuity Pathway Analysis elucidated that 19 genes including Tbx2 were related to BMP pathway and showed significantly altered expression levels by transient expression of Smad9. We confirmed by qRT-PCR that only Tbx2, but not other Tbx families, were induced by Smad9. Importantly, the expression of Tbx2 was more up-regulated by Smad9 than by Smad1. Moreover, we identified Asb2 as a specific E3 ligase that targets Smad9, but not Smad1/5, for proteasomal degradation. The in situ hybridization using murine embryo revealed that Asb2 is expressed predominantly in the heart during embryonic development, suggesting that Asb2 quantitatively regulates Smad9 in the developing heart. Biochemical analysis demonstrated that Tbx2 expression induced by Smad9 was attenuated by Asb2, which was restored by the treatment with proteasome inhibitor, lactacystin. Developmental studies using both P19CL6 cells and zebrafish showed that the ablation of Asb2 leads accumulation of Smad9 resulting in the up-regulation of Tbx2, which attenuates myocardial development while induces non-myocardial tissue including cardiac cushion. Indeed, alcian blue staining of morpholino-mediated knockdown of zebrafish Asb2 showed significantly dilated ventricle and thinned ventricular wall, accompanied with decreased myocardium and increased cardiac jelly. Conclusions: Smad9 induces the expression of Tbx2 during cardiac development and is temporally and quantitatively regulated by its specific E3 ligase Asb2. This is the first study to show both the target gene and specific E3 ligase of Smad9.


2019 ◽  
Author(s):  
Jerome Perrard ◽  
Adrien Morel ◽  
Koceila Meznad ◽  
Philippe Paget‑Bailly ◽  
Veronique Dalstein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document